IP Library › Assignment 067679/0338
Patent Assignment
Reel/Frame 067679/0338

Assignment of Assignor's Interest

Recorded: 2024-06-10 Pages: 62
Assignor
INHIBRX, INC.
Executed: 2024-05-28
Assignee
INHIBRX BIOSCIENCES, INC.
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CALIFORNIA, 92037
Covered Properties (49)
Multivalent and Multispecific 41BB-Binding Fusion Proteins
Application: 15/404,016 →
Publication: US 2017/0198050
PDL1-Binding Proteins
Application: 16/601,825 →
Publication: US 2020/0199243
Multivalent and Multispecific 41BB-Binding Proteins
Application: 18/067,484 →
Publication: US 2023/0416387
Multivalent and Multispecific CD137-Binding Fusion Proteins
Application: 62/277,028 →
CD123-Binding Polypeptides and Uses Thereof
Application: 16/864,478 →
Publication: US 2020/0347142
CD123-Binding Polypeptides and Uses Thereof
Application: 17/816,540 →
Publication: US 2023/0065306
CD123-Binding Polypeptides and Uses Thereof
Application: 62/843,407 →
CD123 Targeted Immunotherapies
Application: 17/608,739 →
Publication: US 2022/0315638
CD123 Targeted Immunotherapies
Application: 62/845,307 →
CD33-Binding Polypeptides and Uses Thereof
Application: 16/864,480 →
Publication: US 2020/0347133
CD33-Binding Polypeptides and Uses Thereof
Application: 18/067,504 →
Publication: US 2023/0312716
CD33-Binding Polypeptides and Uses Thereof
Application: 62/843,408 →
CD33-Binding Polypeptides and Uses Thereof
Application: 62/844,359 →
CD33 Targeted Immunotherapies
Application: 17/608,743 →
Publication: US 2022/0324942
CD33 Targeted Immunotherapies
Application: 62/845,304 →
CD33 Targeted Immunotherapies
Application: 62/898,392 →
CD8-Binding Polypeptides and Uses Thereof
Application: 18/578,133 →
CD8-Binding Polypeptides and Uses Thereof
Application: 63/223,786 →
CD8-Binding Polypeptides and Uses Thereof
Application: 63/288,111 →
CD8-Targeted Modified IL-2 Polypeptides and Uses Thereof
Application: 18/578,137 →
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application: 63/223,798 →
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application: 63/288,113 →
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application: 63/296,775 →
CLEC12a Binding Polypeptides and Uses Thereof
Application: 16/864,481 →
Publication: US 2020/0347139
CLEC12a-BINDING POLYPEPTIDES AND USES THEREOF
Application: 62/843,411 →
CLEC12a-BINDING POLYPEPTIDES AND USES THEREOF
Application: 62/844,426 →
Cll-1 Targeted Immunotherapies
Application: 17/608,738 →
Publication: US 2022/0323496
Cll-1 Targeted Immunotherapies
Application: 62/845,306 →
Canine PD-1-Binding Polypeptides and Uses Thereof
Application: 17/922,569 →
Publication: US 2023/0331846
Canine PD-1-Binding Polypeptides and Uses Thereof
Application: 63/019,817 →
Multivalent and Multispecific DR5-Binding Fusion Proteins
Application: 15/213,296 →
Publication: US 2017/0015753
Multivalent and Multispecific DR5-Binding Fusion Proteins and Methods of Treating Neoplasms
Application: 16/387,754 →
Publication: US 2019/0309083
Multivalent and Multispecific DR5-Binding Fusion Proteins and Methods of Modulating Immune Cells
Application: 17/394,900 →
Publication: US 2022/0064318
Multivalent and Multispecific DR5-Binding Fusion Proteins
Application: 18/626,699 →
Publication: US 2024/0376220
Multivalent and Multispecific DR5-Binding Fusion Proteins
Application: 62/193,309 →
Formulations of DR5 Binding Polypeptides
Application: 18/264,475 →
Formulations of DR5 Binding Polypeptides
Application: 63/151,131 →
DR5 Agonist and PLK1 Inhibitor Combination Therapy
Application: 63/328,951 →
DR5 Agonist and IAP Antagonist Combination Therapy
Application: 63/344,675 →
DR5 Agonist and IAP Antagonist Combination Therapy
Application: 63/494,276 →
FcRn-Binding Polypeptides and Uses Thereof
Application: 63/351,363 →
FcRn-Binding Polypeptides and Uses Thereof
Application: 63/437,776 →
Albumin-Binding Polypeptides and Uses Thereof
Application: 63/338,629 →
Albumin-Binding Polypeptides and Uses Thereof
Application: 63/351,362 →
IgE Binding Polypeptides and Uses Thereof
Application: 63/526,570 →
IgE Binding Polypeptides and Uses Thereof
Application: 63/605,695 →
Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof
Application: 17/418,458 →
Publication: US 2022/0089667
Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof
Application: 62/789,075 →
Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof
Application: 18/002,613 →
Publication: US 2023/0235005
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 038281/0972 →
Assignment of Assignor's Interest Jun 26, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 042816/0394 →
Merger and Change of Name May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Assignment of Assignor's Interest Jul 22, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 049822/0562 →
Assignment of Assignor's Interest Jul 22, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 049822/0539 →
Assignment of Assignor's Interest Jul 22, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 049822/0579 →
Assignment of Assignor's Interest Aug 16, 2019
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 050069/0688 →
Assignment of Assignor's Interest Aug 16, 2019
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 050069/0679 →
Assignment of Assignor's Interest Sep 4, 2019
From: MACEDO, CHELSIE; JONES, KYLE; CRAGO, WILLIAM; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 050265/0715 →
Assignment of Assignor's Interest Sep 4, 2019
From: RASCON, LUCAS
To: INHIBRX, INC.
Reel/Frame 050267/0097 →
Assignment of Assignor's Interest Sep 4, 2019
From: MACEDO, CHELSIE; JONES, KYLE; CRAGO, WILLIAM; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 050265/0739 →
Assignment of Assignor's Interest Nov 27, 2019
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 051130/0106 →
Assignment of Assignor's Interest Feb 25, 2020
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 051913/0494 →
Assignment of Assignor's Interest Apr 20, 2020
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 052440/0803 →
Assignment of Assignor's Interest Apr 20, 2020
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 052440/0779 →
Assignment of Assignor's Interest Sep 14, 2021
From: BLUEBIRD BIO, INC.
To: 2SEVENTY BIO, INC.
Reel/Frame 057683/0099 →
Assignment of Assignor's Interest Oct 20, 2021
From: TIMMER, JOHN C.; CRAGO, WILLIAM; SULZMAIER, FLORIAN; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 057847/0881 →
Assignment of Assignor's Interest Oct 20, 2021
From: TIMMER, JOHN C.; CRAGO, WILLIAM; SULZMAIER, FLORIAN; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 057847/0877 →
Intellectual Property Security Agreement Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059182/0041 →
Assignment of Assignor's Interest Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0824 →
Assignment of Assignor's Interest Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0749 →
Assignment of Assignor's Interest Jul 13, 2022
From: TIMMER, JOHN C.; CRAGO, WILLIAM; SULZMAIER, FLORIAN; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 060492/0863 →
Assignment of Assignor's Interest Jul 13, 2022
From: TIMMER, JOHN C.; CRAGO, WILLIAM; SULZMAIER, FLORIAN; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 060492/0840 →
Assignment of Assignor's Interest Sep 1, 2022
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 060969/0480 →